Summary

for people ages 2 months and up (full criteria)
at San Francisco, California and other locations
study started

Description

Summary

Provide patients with serious AdV infection or disease access to treatment with BCV.

Official Title

An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

Keywords

Adenovirus Adenovirus Brincidofovir Adenoviridae Infections Brincidofovir

Eligibility

You can join if…

Open to people ages 2 months and up

  • Confirmed serious AdV infection based on clinical symptoms and laboratory testing showing AdV in the blood or other bodily fluids
  • Able to swallow medication, either tablet or liquid

You CAN'T join if...

  • Previous dosing with Brincidofovir
  • If female, not pregnant or trying to become pregnant

Locations

  • University of California San Francisco Benioff Children's Hospital
    San Francisco California 94143 United States
  • Pediatric Stem Cell Transplantation Stanford University
    Palo Alto California 94304 United States
  • Stanford University
    Palo Alto California 94304 United States

Details

Status
not accepting new patients
Start Date
Sponsor
Chimerix
ID
NCT02596997
Study Type
Expanded Access
Last Updated